Chimerix Inc (CMRX) - News Archive

Dordaviprone Addresses a Significant Unmet Patient Need for Patients with Rare, High-Grade Brain TumorsIn the fast-evolving landscape of oncology, innovative solutions are paramount in addressing the stark realities of...

Chimerix Continues to Expand Its Workforce with Inducement Grants Under Nasdaq Rule 5635(c)(4)Chimerix, a biotechnology firm based in Durham, North Carolina, is maintaining an active recruitment strategy as it looks to...

Chimerix Grants Inducement Award to New Employee Under Nasdaq Rule 5635(c)(4)In the realm of biotech investments and corporate development, Chimerix, Inc. (NASDAQ: CMRX) has demonstrated a strategic approach to attracti...

Chimerix, a leading biopharmaceutical company based in Durham, North Carolina, recently announced the granting of an inducement award to a new employee under the Nasdaq Listing Rule 5635(c)(4). This article will outline...

In a recent press release, Chimerix (NASDAQ:CMRX) announced the granting of inducement awards to two new employees in the form of non-statutory stock options. This move, approved by the Compensation Committee of Chimeri...

In a recent press release, Chimerix (NASDAQ: CMRX), a leading biopharmaceutical firm based in Durham, N.C., announced the granting of inducement awards to four new employees. The Compensation Committee of Chimerix s Boa...